Quantum BioPharma purchases 2,000 shares of GameStop

Quantum BioPharma (QNTM) announced the purchase of 2,000 shares of GameStop (GME) to hold on the Company’s balance sheet as a strategic investment. The company said, “This move aligns with Quantum BioPharma’s ongoing commitment to combating market corruption and enhancing shareholder value through prudent financial strategies and advocacy against manipulative trading practices. The Company has been at the forefront of fighting market corruption, as evidenced by its recent appointments of advocates like Board Advisor Kevin Malone and Director Terry Lynch, both known for their crusades against naked short selling and stock manipulation. Mr. Malone is the CEO and sole owner of Malone Wealth Ventures,, an investment advisory firm based in California, which provides comprehensive asset management and investment advice to its clients with various strategies. Malone Wealth Ventures served as a consultant to the Company from April 22, 2025, and received 30,000 shares and 60,000 RSU’s of the Company’s Class B Subordinate Voting Shares as compensation for its consulting services. Malone Wealth Ventures, currently owns, on behalf of its clients, 829,730 Class B Shares, representing approximately 21.8% of the Company’s issued and outstanding Class B shares as of July 20, 2025, as reported in its Schedule 13G/A filed on July 18, 2025. The Company has also pursued aggressive legal action, including an amended complaint filed against CIBC World Markets, RBC Dominion Securities, and others seeking damages exceeding $700M for alleged stock price manipulation through spoofing techniques between January 2020 and August 2024. These efforts underscore Quantum BioPharma’s dedication to protecting investors from fraudulent practices that undermine stock market integrity.”